skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have been reading about AI supporting better diagnostics in health care (ER’s, primary care etc) and that it there is much work being done to improve health care AI even more.
Which companies in the US and Canada are promising players here that you would invest in to play into this theme?

Sending all of you folks at 5i much appreciation - thanks so much for all you do!
Read Answer Asked by Josh on May 06, 2026
Q: The symbol for my Thomson Reuters Corp has changed to 66543D today. My online broker told me that this is because of a merger with another company, could you elaborate on this? I have been holding ABT for more than 5 years now and I am in negative territory with this stock today. Would you buy more, hold or simply sell for something better in the health care sector? Thank you
Read Answer Asked by Gervais on May 05, 2026
Q: On April 28, 2026, Dr. Reddy’s Laboratories became the first company approved by Health Canada to sell a generic version of the popular diabetes and weight-loss drug Ozempic (semaglutide).

While Dr. Reddy's is an international company with a significant presence in Canada, they are the first to pass the regulatory hurdles for this specific drug in Canada.

would you have any comments re: if one could invest in Dr Reddy's stock? I think the demand for OZEMPIC will increase
can you suggest an entry point? thanks
Michael
Read Answer Asked by Michael on April 30, 2026
Q: As portfolios should be diversified, the following names are owned, yet are not doing well, except SYK/MRK. Are any of these outright sells or just not the flavour of the day?Thank you for your excellent advice!
Read Answer Asked by Neil on April 29, 2026
Q: A number of Health Care names have lagged the current market. I have bought half positions in LLY and ISRG recently and they have pulled back. I know you like both these companies, would you be adding to these names at these prices or do you have other health care names you prefer?

Why do you think the Healthcare Sector has lagged the recent market uptick?

Thanks
Tim
Read Answer Asked by Timothy on April 27, 2026
Q: According to portfolio analytics, I'm seriously underweight in Healthcare, something which I should probably correct. Any of these names herein stick out as great buys in healthcare. US or CAD, no difference to me. Thank you.
Read Answer Asked by Sylvia on April 16, 2026
Q: Can I get your thoughts on LMAT please. Seems to be doing well. Near its 52 week highs. Thank You
Read Answer Asked by Stephen on April 14, 2026
Q: I am revisiting my inquiry regarding UnitedHealth Group (UNH) from January 27, 2026. Given today’s news that CMS has finalized a 2.48% Medicare Advantage rate hike for 2027—a significant shift from the restrictive proposal that triggered the January volatility—I would appreciate an update of your perspective now.
Specifically, does this "clearing of the clouds" establish a sufficient regulatory floor to justify a sustained, long-term hold? Or, considering the ongoing margin pressures on the insurance side, should today’s price strength be viewed primarily as a strategic opportunity to exit or trim a position that was heavily impacted ( value slashed in half) last year?
Is the current fundamental reset a "buy the bottom" confirmation for a scale player like UNH, or a "sell the news" event? (held in tax-deferred account) . :ao:
Read Answer Asked by Adam on April 09, 2026
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!